Menu
Your Cart

Apostle Viral RNA/DNA Isolation Automation System

 Apostle’s response and solution to help our community fight COVID-19 together.

Feature: High Quality, Low Cost, Fast, Safe

  • High quality: Equal or better results compared with market leading products.
  • Lower cost: Guaranteed 30% - 50% less cost than other products on market.
  • Faster: One button start; Run time is approximately 40 minutes per 96 samples.
  • Safer: Integrated with a UV light for unit interior disinfection.

Contributed to COVID-19 testing in over 15 million people by our clients.

What our community say

"An instance of sequential infection of an individual with, firstly, the Delta variant and secondly a Delta-sub-lineage has been identified. The individual was found positive for the AY.26 lineage 22 days after being found positive for the Delta [B.1.617.2] variant...Nucleic acid extractions were performed by Apostle MagTouch Nucleic Acid Extraction Automation Systems [Apostle Inc, San Jose, CA]. "
- An independent clinical study published in Diagnostic Microbiology and Infectious Disease by Nevada State Public Health Laboratory
Apostle COVID-19 RNA Extraction System is a fast and reliable solution for SARS-CoV-2 viral RNA extraction. We look forward to continuing the collaboration with Apostle and providing high quality COVID-19 tests for our community.
- Harry Gao, MD, PhD, DABMG, FACMG, Lab Director and Chief Scientific Officer, Fulgent Genetics
With Apostle automation, my team and I have been able to develop a method to detect and quantify SARS-CoV-2 in wastewater samples, while also having the ability to sequence viral RNA from the wastewater samples. ...Apostle was able to quickly supply us with instruments, plates and reagents for a fraction of the price of the competitors. Apostle has been a great partner for us. Their technical support team programmed our MagTouch 2000 at no cost, and their team was supportive and accommodating every step of the way.
- Lauryn Massic, Association of Public Health Laboratories infectious disease fellow at the Nevada State Public Health Laboratory. (Read Interview)

Inclusion in US FDA IVD EUA - Molecular Diagnostic Tests for SARS-CoV-2



 

MagTouch Automated Nucleic Acid Isolation System & MiniGenomics Viral TotalNA Isolation Fast Kit

Highlighted Features

  • Extremely robust and reliable; sustained 7x24 heavy use for 2+ years in very busy clinical laboratory environment (as in the photo exhibit)
  • Cost-effective; guaranteed 30% or more savings than other products 
  • High-efficiency and high-throughput extraction
  • Small footprint on the desktop
  • Improved color touchscreen interface and one-button start
  • Removable transparent cover – convenient for automatic liquid transfer workstation 
  • Build-in UV light for sterilization
  • Programmable procedure
  • Novel magnetic field settings for high recovery of magnetic beads
  • Ten different mixing speeds
  • Vibration extent of the magnetic head automatically matches the reagent volume during mixing
  • Precise temperature control between ambient temperature -120 °C

Environmental Requirements

  • Surrounding temperature: 10℃ - 35℃
  • Humidity below 70% 
  • Atmosphere pressure range: 500 – 1060 hpa 
  • Voltage requirements: AC 100-240 V, 50Hz / 60Hz
  • Operation desk
  • Located in well-ventilated room 
  • Bearing weight beyond 50kg

Modules

    NumberModulesDescription of Functions
    1Plastic tip comb moduleMixing; transfer magnetic beads
    2Magnetic head moduleMagnetization of beads
    3Turntable moduleSwitch of plates
    4Thermal module （optionalTemperature control
    5Shield modulePrevent potential cross contamination
    6UV sterilization moduleSterilization 
    7Working lamp moduleIllumination

    Documentation

      • This links directs to an Application Note on the Apostle COVID-19 Viral RNA Extraction System, applied in the effective detection of SARS-CoV-2 in over 8 million clinical samples by our clients. Using Apostle system, limit of Detection (LoD) of the downstream detection system of our customer is documented at 3.6 NDU/uL published on the FDA website. The sensitivity and specificity is 99.9% and 99.9% at 3 copies/uL, respectively, published on our customer’s website.
    • Apostle-COVID-19-Viral-RNA-Isolation-System.pdf
      • This link directs to download the product brochure.
    • Apostle-MiniGenomics-Viral-Total-NA-Isolation-MagTouch-protocol.pdf
      • This link directs to download the system protocol.
    • Apostle-MagTouch-2000-manual.pdf
      • This link directs to download the user manual for Apostle MagTouch 1000 Nucleic Acids Isolation Automation System
    Order COVID-19 Related Products
    All Publications
    Nature Communications just published a clinical study, including 2125 cancer patients, 9 cancer types, using the Apostle Minimax cfDNA technology. This study demonstrates the ability of its model to detect early-stage cancers using cfDNA, including those of pancreatic origin, with high sensitivity that is comparable to that of late-stage detection. Congratulations to this clinical research team. To date, the Apostle Minimax cfDNA technology has been used in 2 articles published in Nature Medicine, 1 in Nature Communications, 1 in Science Translational Medicine, 1 in PNAS, and over 50 scientific articles in different journals.